We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current SHEZF market cap is 158.6M. The company's latest EPS is CNY -3.5587 and P/E is -0.20.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 4.6B | 5.31B | 6.34B | 7.14B | 5.42B |
| Operating Income | 1.71B | 2.06B | 2.01B | 2.31B | 1.78B |
| Net Income | 1.06B | 1.02B | 240.79M | 727.08M | -783.26M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 15.24B | 19.03B | 19.11B | 20.81B | 19.2B |
| Total Liabilities | 7.77B | 7.34B | 7.58B | 8.41B | 7.22B |
| Total Equity | 7.47B | 11.69B | 11.52B | 12.41B | 11.99B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | -227.6M | 37.28M | -6.63M | -756.61M | 398.22M |
| Investing | 1.7M | -2.17B | 719.93M | 249.84M | 1.22B |
| Financing | -234.34M | 2.51B | -501.08M | 329.56M | -1.21B |
| Market Cap | 158.6M |
| Price to Earnings Ratio | -0.20 |
| Price to Sales Ratio | 0.03 |
| Price to Cash Ratio | 0.09 |
| Price to Book Ratio | 0.01 |
| Dividend Yield | - |
| Shares Outstanding | 220.09M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.08 (17.18%) |
| Company Name | Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK) |
| Address |
the no. 21 on songping mountain road shenzhen, guangdong 518057 |
| Website | https://www.hepalink.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
